Chemoimmunotherapy or BTK inhibition for patients with CLL
20 Jun 2019
Chemoimmunotherapy or BTK inhibition for patients with CLL
CLL14: A chemotherapy-free regimen of venetoclax plus obinutuzumab for CLL
Cancer care in Latin America
ASCO 2019 and vision for cancer control
Better education about breast cancer treatment in Africa
Predictive models for treatment risk in cancer
Improving radiotherapy access in Africa
The global program of the American Cancer Society
Barriers to cancer care in Africa
The Global Health Catalyst initiative
The role of cancer surgery in Africa
A super-fast, cloud-based, AI imaging system for radiotherapy